Both insulin aspart and insulin lispro, rapid-acting insulin analogs, control postprandial blood glucose in type 1 diabetic patients, according to a report in the November issue of Diabetes Care. Dr. Johannes Plank, of Karl-Franzens University, Graz, Austria, and colleagues compared the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro in type 1 diabetic subjects.
In addition, they examined whether one analog results in favorable effects on prandial blood glucose control.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!